TCR CDR3s and Renalase-1 Linked to Increased Melanoma Survival
August 8, 2024
These findings indicate that renalase-1 is a potential antigen for TCR recognition in melanoma and could be considered as a target for immunotherapy.”BUFFALO, NY- August 8, 2024 – A new... read more